Had a fantastic time at PrecisCa 2024 - Matthew Kurian, MD
Mohammad Jahanzeb Joyce O'Shaughnessy, MD Narjust Florez, MD, FASCO Edgardo S. Santos, M.D., FACP, FASCO Jeffrey Patton Jasgit S@phase1AZ Guru P. Sonpavde, MD Sanjay Juneja, MD Kashyap Patel, MD Wally Curran FLASCO Community Oncology
oncodaily.com/59268.html

#Cancer #OncoDaily #Oncology #PrecisCa

KMA welcomes new members Matthew Kurian, M.D., St. Elizabeth Physicians- Edgewood Cancer Care, Olga Melzer, M.D., St. Elizabeth Physicians Hospitalist - Florence, and Hani Murad, M.D., St. Elizabeth Pulmonology/Critical Care - Edgewood, to the KMA family.

Thank you PrecisCa for introducing me to these wonderful panel of mentors who are guiding us to become better physicians & patient advocates!
Tanya Gupta
Matthew Kurian, MD Jennifer Marks, MD Jasmin Hundal, M.D., M.S., M.P.H.
Anusha MD
Samuel Kareff, MD, MPH Sabrina Matos Narjust Florez, MD, FASCO
Riya Patel, MD

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉Excellent talk by Heather H. Cheng on who should undergo germ line testing?👉ongoing neoadjuvant trials in germline mutation+ #prostatecancer and take home message👇OncoAlert PCF Science silke gillessen

We are so excited to have the @uromigos back for kidney cancer board review & 2024 updates

First up with Localized RCC discussing risk factors, who needs genetic testing, who qualifies for adjuvant therapy…& who’s a faster swimmer btw Brian Rini, MD & Tom Powles

Approved in HER2-low based on DESTINY-Breast04

DESTINY-Breast06 ongoing to see if we can further expand to HER2 “ultralow”

aacrjournals.org/cancerdiscover… Cancer Discovery

Had a fantastic time at PrecisCa 2024! Truly one of my favorite conferences of the year being able to meet and interact with some of the leaders in our field and catching up with colleagues and friends, being part of the expert panel, and sharing my experience with fellows.

Sharing how to go from being a fellow to an attending ⁦Rachel Layman⁩ #DrLakeLittlejohn ⁦Matthew Kurian, MD⁩ with ⁦PrecisCa⁩ ⁦♡Sherry Crowe♡⁩ ⁦MD Anderson Cancer Center⁩ ⁦St. Elizabeth HC⁩ ⁦Texas Oncology⁩ being a generalist is a common pathway

Very excited to meet Karine Tawagi MD from TwoOncDocs, Sanjay Juneja, MD , Narjust Florez, MD, FASCO from #FlorezLab ,Matthew Kurian, MD, eminent faculty & fellows at the
PrecisCa's 2nd Annual Oncology Fellows Forum & Expert Faculty Retreat -Developing Oncology’s future emerging leaders 🎗

Excited to share our publication of T-DXd vs. T-DM1 in pts with brain 🧠 mets from DB-03.

⭐️ PFS 15 months w/T-DXd vs. 3 months w/ T-DM1

Trastuzumab deruxtecan vs trastuzumab emtansine in brain metastases in DESTINY-Breast03 trial - ESMO Open esmoopen.com/article/S2059-…

Updated data with lenvatinib and Pembrolizumab in 158 1st line advanced non-clear cell renal cancer #ikcs24 . 8 mnths extra FU. RR= 50% seems higher than sunitinib. 18 month mPFS and 80% 12 month OS also looks ⬆️, but randomised trials such as SAMETA and XL92/nivo remain important

Trial in progress: the HER2/MMAE ADC disitimab Vedotin +pembro vs chemotherapy +\-avelumab in advanced UC(HER2+ve). DVs efficacy looks ⬆️ also with IO. Tox profile looks distinct with ? ⬇️ skin tox? #EAU24 Results will be considered in the context of other +ve 1st line studies

Excited to serve and be part of ASCO TECAG with my colleague and buddy Jacob J. Adashek, DO and many others! Look forward to working with you all! @ASCO #earlycareer #asco2025

Recurrence data from the #PHERGain phase 2 trial published on The Lancet. A de-escalated, PET-response-based neoadjuvant treatment strategy for stage I-IIIA HER2+ breast cancer led to 94.8% 3-year iDFS rate and halved the incidence of severe AEs. #bcsm
thelancet.com/journals/lance…

Integrating AI into our everyday practice and decision-making - Matthew Kurian, MD
H. Jack West, MD Jacob J. Adashek, DO JAMA Oncology

#Cancer Care #Oncology #Cancer #JAMAOncology #OncoDaily

oncodaily.com/44168.html

🔥HOT🔥OFF THE PRESS📰in JAMA Oncology w/St. Elizabeth Matthew Kurian, MD Summit Therapeutics H. Jack West, MD 'Cancer Care in the Era of Artificial Intelligence🖥️' helping patients navigate cancer care in the era of AI‼️bit.ly/43GVBaD

Important analyses from FDA Oncology led by Dr Fallah and team from a pooled analysis of RCT

OncoAlert European Urology

🤩Applications are 📭OPEN for GRACE Ambassador Program! I have been so fortunate to be part of this program w/Ivy Riano, M.D. Matthew Kurian, MD Meera Ragavan, MD MPH Gladys M. Rodriguez, MD, MS karan jatwani Kaitlin Kyi, MD! I encourage you to apply🌟! bit.ly/48A36RK